PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-09-17

Date Title Company
17-Sep-2023 Enanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference Businesswire